Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Hirotaka, Takasaki"'
Autor:
Tomohiro Aoki, Koji Izutsu, Ritsuro Suzuki, Chiaki Nakaseko, Hiroshi Arima, Kazuyuki Shimada, Akihiro Tomita, Makoto Sasaki, Jun Takizawa, Kinuko Mitani, Tadahiko Igarashi, Yoshinobu Maeda, Noriko Fukuhara, Fumihiro Ishida, Nozomi Niitsu, Ken Ohmachi, Hirotaka Takasaki, Naoya Nakamura, Tomohiro Kinoshita, Shigeo Nakamura, Michinori Ogura
Publikováno v:
Haematologica, Vol 99, Iss 12 (2014)
The prognosis of patients with primary mediastinal large B-cell lymphoma has improved over recent years. However, the optimal treatment strategy including the role of radiotherapy remains unknown. We retrospectively analyzed the clinical outcomes of
Externí odkaz:
https://doaj.org/article/b514f320357e478487d2ef3ca3592544
Autor:
Rika Sakai, Koji Miyazaki, Reiko Watanabe, Hiroyuki Takahashi, Yasufumi Ishiyama, Yukako Hattori, Maki Hagihara, Ken Ohmachi, Kazuhito Yamamoto, Hirotaka Takasaki, Eri Tanaka, F Sano, Masatsugu Tanaka, Kiyoshi Ando, H Kimura, Madoka Takimoto, Naoto Tomita, Yoshimi Ishii, Takayoshi Tachibana
Publikováno v:
Annals of Hematology. 98:2131-2138
The optimal dose, schedule, and other aspects of bendamustine plus rituximab treatment remain unclear for patients with relapsed or refractory follicular lymphoma (FL). Herein, we analyzed the efficacy of bendamustine combined with rituximab (RB-120)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ca9315f63c8ae4d0530f6aeb127e908
https://doi.org/10.1007/s00277-019-03750-7
https://doi.org/10.1007/s00277-019-03750-7
Autor:
Yuki Nakajima, Kumiko Kishimoto, Katsumichi Fujimaki, Taisei Suzuki, Hideaki Nakajima, Yoshimi Ishii, Shin Fujisawa, Yukako Hattori, Yasufumi Ishiyama, Takuya Miyazaki, Jun Taguchi, Taiki Ando, Hirotaka Takasaki, Hideyuki Koharazawa, Kenji Matsumoto, Rika Sakai
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 14:e455-e459
Aim Primary malignant lymphomas arising from the female genital tract are very rare, with an incidence rate of 0.5%. Because of its rarity, its clinical characteristics, prognosis and optimal treatment are still unclear. Here, we retrospectively eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cacfbc316be87a6d383f145b4610885
https://doi.org/10.1111/ajco.13049
https://doi.org/10.1111/ajco.13049
Autor:
Hirotaka Takasaki, Takayoshi Tachibana, Masatsugu Tanaka, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori
Publikováno v:
Case Reports in Hematology, Vol 2011 (2011)
A 68-year-old man was admitted to our hospital in September 2008 because of a left-sided chest pain. Bone marrow examination showed that 85.5% of leukemic cells were positive for myeloperoxidase (MPO) and were negative for esterase stain. Flow cytome
Externí odkaz:
https://doaj.org/article/517f8d51695b4af0885433aff104fd5c
Autor:
Rika Sakai, Masaki Suzuki, Atsushi Muroi, Yohei Miyagi, Hirotaka Takasaki, Ayumi Numata, Masanori Nojima, Naohiko Koshikawa, Tomoyuki Yokose
Publikováno v:
Proteomics. Clinical applications. 14(1)
Purpose Diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma, is a heterogeneous lymphoma with different clinical manifestations and molecular alterations, and several markers are currently being measured routinely for its diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a294899494be15bad49fc3f06128e6c1
https://pubmed.ncbi.nlm.nih.gov/32109350
https://pubmed.ncbi.nlm.nih.gov/32109350
Autor:
Hirotaka Takasaki, Katsuhiko Masudo, Yasushi Rino, Nobuyasu Suganuma, Rika Sakai, Hiroyuki Iwasaki, Hirotaka Nakayama, Haruhiko Yamazaki, Munetaka Masuda
Publikováno v:
Medicine
Some patients with differentiated thyroid cancer (DTC) may require an initial low dose (LD) of lenvatinib. However, few studies have investigated the efficacy of LD lenvatinib. We compared the efficacy and tolerability of lenvatinib at an initial LD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec9e02220cf84645bbe9e64b180cfdc
http://europepmc.org/articles/PMC6417556
http://europepmc.org/articles/PMC6417556
Autor:
Shin Fujisawa, Rika Kawasaki, Yuki Nakajima, D. Ishibashi, R. Watanabe, Sachiya Takemura, Hirotaka Takasaki, Hideyuki Koharazawa, Naoto Tomita, Kenji Motohashi, Chizuko Hashimoto, Satoshi Koyama, Rika Sakai, Yoshimi Ishii, Yutaka Hattori, Etsuko Yamazaki, S. Motomura, Megumi Itabashi, Hideaki Nakajima
Publikováno v:
International Journal of Laboratory Hematology. 39:112-117
SummaryIntroduction The prognostic value of serum ferritin level in patients with peripheral T-cell lymphoma (PTCL) remains unknown. Methods We retrospectively analyzed clinical data from 78 consecutive patients with newly diagnosed PTCL that were tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2567e65f05ff34d38af8e37ed6079e
https://doi.org/10.1111/ijlh.12592
https://doi.org/10.1111/ijlh.12592
Autor:
Katsuhiko Masudo, Nobuyasu Suganuma, Haruhiko Yamazaki, Hirotaka Takasaki, Hirotaka Nakayama, Soji Toda, Hiroyuki Iwasaki, Shinsuke Hatori, Rika Sakai
Publikováno v:
Oncology letters. 17(6)
In patients with distant metastasis, treatment for differentiated thyroid cancer (DTC) includes complete total thyroidectomy, followed by radioactive iodine (RAI) therapy for metastatic lesions. Tyrosine kinase inhibitor (TKI) treatment is the final
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e368335129869fd2cc854b1acbe41cea
https://pubmed.ncbi.nlm.nih.gov/31186746
https://pubmed.ncbi.nlm.nih.gov/31186746
Autor:
Katsuhiko Masudo, Nobuyasu Suganuma, Hirotaka Takasaki, Soji Toda, Haruhiko Yamazaki, Hirotaka Nakayama, Hiroyuki Iwasaki
Anaplastic thyroid cancer (ATC) is associated with an extremely poor prognosis and is resistant to the majority of chemotherapies. In 2015, lenvatinib was approved for treating ATC in Japan. The present study aimed to evaluate the overall survival (O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c6b40be623ae6c8ded475b63e4a8ce
https://europepmc.org/articles/PMC6256365/
https://europepmc.org/articles/PMC6256365/
Autor:
Masataka Taguri, Yukako Hattori, Wataru Yamamoto, Chizuko Hashimoto, Yoshimi Ishii, Takuya Miyazaki, Hirotaka Takasaki, Takayoshi Tachibana, Katsumichi Fujimaki, Naoto Tomita, Yoshiaki Ishigatsubo, Taisei Suzuki, Yuki Nakajima, Yasufumi Ishiyama, Rika Sakai, Etsuko Yamazaki, Kazuho Miyashita, Kenji Matsumoto, Shigeki Motomura, Sachiya Takemura, Ayumi Numata
Publikováno v:
Leukemia Research. 39:1187-1191
Useful prognostic markers for patients with diffuse large B cell lymphoma (DLBCL) have been reported. To identify which biomarker best predicts the prognosis of patients with DLBCL, we performed a retrospective study that included 319 DLBCL patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::558cfd5a5a3faddb173b11fbb4d84658
https://doi.org/10.1016/j.leukres.2015.08.016
https://doi.org/10.1016/j.leukres.2015.08.016